TCL Archive BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor. By Cancer History Project September 28, 2001
TCL Archive FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment. By Cancer History Project September 28, 2001
TCL Archive Impath Buys Clinical Studies Support Services Network. By Cancer History Project September 28, 2001
TCL Archive MGI Pharma, MethylGene Begin Phase II Trial Of MG98. By Cancer History Project September 28, 2001
TCL Archive Vasopermeation Technology Awarded Patent For CA Firm. By Cancer History Project September 28, 2001
TCL Archive FDA Approves Xeloda For Breast Cancer Treatment. By Cancer History Project September 28, 2001
TCL Archive NCI “Much Stronger” Now, Rimer Says In Note To Staff. By Cancer History Project September 21, 2001
TCL Archive NCI Director Klausner Resigns To Head Institute Begun By AOL Chairman Case. By Cancer History Project September 14, 2001
Article Fran Visco tells the story of NBCC: “Women have declared war on breast cancer” By Cancer History Project
